Utility of propensity score-based Bayesian borrowing of external adult data in pediatric trials: A pragmatic

Antara Majumdar1, Rebecca Rothwell2, Gregory Reaman3

  • 1Oncology Biostatistics, GlaxoSmithKline, Collegeville, PA, USA.

Insights

Conducting pediatric cancer trials is difficult due to low patient numbers. This study uses Bayesian methods and propensity score matching to borrow data from adult trials, improving pediatric trial feasibility and assessment.

Area of Science:

  • Biostatistics
  • Pediatric Oncology
  • Clinical Trial Design

Background:

  • Pediatric cancer clinical trials face enrollment challenges due to low disease incidence.
  • Leveraging external adult trial data can enhance pediatric trial feasibility when appropriate.
  • Bayesian analysis offers a method for integrating external adult data into pediatric trial assessments.

Purpose of the Study:

  • To investigate methods for effectively borrowing information from external adult cancer trials for pediatric trials.
  • To assess the utility of propensity score matching in selecting relevant adult subjects for data borrowing.
  • To examine the application of Bayesian mixture and power priors in pediatric trial efficacy assessment using external data.

Main Methods:

  • Utilized Bayesian analysis to augment pediatric trial data with external adult trial data.
  • Employed propensity score matching to align external adult subjects with pediatric subjects based on clinical covariates.
  • Applied propensity score matched mixture and power priors for information borrowing in a pediatric acute lymphoblastic leukemia (ALL) case study.

Main Results:

  • Propensity score matching effectively identified clinically relevant adult subjects for data borrowing.
  • Bayesian methods, incorporating matched external data, improved the assessment of pediatric trial efficacy.
  • Demonstrated the utility of this approach in a case study of pediatric acute lymphoblastic leukemia (ALL).

Conclusions:

  • Propensity score matched Bayesian methods enhance the feasibility and statistical power of pediatric cancer trials.
  • Borrowing information from carefully selected external adult trials is a viable strategy for pediatric oncology research.
  • Considerations for scaling fixed borrowing from external adult data were presented.

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
386
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
156
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
337